Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
주식 순위 #17923
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
주가
$18.20
마지막 동기화: 2025-05-09
시가총액
$220.35M
변동 (1일)
-5.34%
변동 (1년)
0.00%
국가
JP
거래 I'rom Group Co., Ltd. (2372)

카테고리

I'rom Group Co., Ltd. (2372)의 발행 주식 수
December 2024 기준 발행 주식 수: 12.11M
I'rom Group Co., Ltd.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 12.11M입니다. March 2023 말 기준 회사는 12.09M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
I'rom Group Co., Ltd. (2372)의 발행 주식 수 기록 (2005 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 12.11M -0.02%
2024 12.11M 0.11%
2023 12.09M 0.19%
2022 12.07M 0.45%
2021 12.02M 2.87%
2020 11.68M 0.23%
2019 11.66M 1.23%
2018 11.51M 5.84%
2017 10.88M 2.51%
2016 10.61M 3.46%
2015 10.26M 7.29%
2014 9.56M 2.23%
2013 9.35M 0.00%
2012 9.35M 0.00%
2011 9.35M 0.00%
2010 9.35M 0.00%
2009 9.35M 0.00%
2008 9.35M 0.13%
2007 9.34M 0.69%
2006 9.28M 11.44%
2005 8.32M 0.00%
유사 기업 또는 경쟁사의 발행 주식 수